Literature DB >> 17236728

Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.

Sarah A Molokhia1, Eun-Kee Jeong2, William I Higuchi1, S Kevin Li3.   

Abstract

Previously, transscleral and transcorneal iontophoretic delivery was studied and compared to passive delivery and intravitreal injection using nuclear magnetic resonance imaging (MRI). The objective of the present study was to employ MRI to further investigate the factors affecting transscleral iontophoretic delivery. In the present study, anodal and cathodal constant current transscleral iontophoresis were conducted with excised sclera in side-by-side diffusion cells in vitro and with rabbits in vivo. The total current and duration of application were 2 and 4mA (current density 10 and 20mA/cm(2)) and 20-60min, respectively. The delivery and distribution of the model permeants manganese ion (Mn(2+)) and manganese ethylenediaminetetraacetic acid complex (MnEDTA(2-)) into the eye during iontophoresis were determined with MRI and compared with the results obtained in previous studies of subconjunctival injection and passive delivery. Both anodal and cathodal iontophoresis provided significant enhancement in ocular delivery compared to passive transport in the in vitro and in vivo experiments. Transscleral iontophoretic delivery was related to the position and duration of the iontophoresis application in vivo. Permeants were observed to be delivered primarily into the anterior segment of the eye when the pars plana was the application site. Extending the duration of iontophoresis at this site allowed the permeants to be delivered into the vitreous more deeply and to a greater extent than when the application site was at the back of the eye near the fornix. The present results show that electrode placement was an important factor in transscleral iontophoresis, and the ciliary body (pars plana) was determined to be the pathway of least resistance for iontophoretic transport. These new findings continue to support the utility of MRI as a noninvasive technique in ocular drug delivery research and testing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17236728      PMCID: PMC1993903          DOI: 10.1016/j.ijpharm.2006.11.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  24 in total

1.  Lontophoresis for the treatment of paecilomyces keratitis.

Authors:  Sonia H Yoo; Dilek Dursun; Sander Dubovy; Darlene Miller; Eduardo Alfonso; Richard K Forster; Francine Behar-Cohen; Jean-marie Parel
Journal:  Cornea       Date:  2002-01       Impact factor: 2.651

2.  Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast.

Authors:  T Watanabe; T Michaelis; J Frahm
Journal:  Magn Reson Med       Date:  2001-09       Impact factor: 4.668

Review 3.  Iontophoresis: a non-invasive ocular drug delivery.

Authors:  Esther Eljarrat-Binstock; Abraham J Domb
Journal:  J Control Release       Date:  2005-12-15       Impact factor: 9.776

4.  Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI.

Authors:  Bruce A Berkowitz; Robin Roberts; Dennis J Goebel; Hongmei Luan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

5.  Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats.

Authors:  F F Behar-Cohen; J M Parel; Y Pouliquen; B Thillaye-Goldenberg; O Goureau; S Heydolph; Y Courtois; Y De Kozak
Journal:  Exp Eye Res       Date:  1997-10       Impact factor: 3.467

6.  A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

Authors:  Michael R Robinson; Susan S Lee; Hyuncheol Kim; Stephanie Kim; Robert J Lutz; Craig Galban; Peter M Bungay; Peng Yuan; Nam Sun Wang; Jonghyeon Kim; Karl G Csaky
Journal:  Exp Eye Res       Date:  2005-09-15       Impact factor: 3.467

7.  Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel.

Authors:  Esther Eljarrat-Binstock; Frederik Raiskup; Joseph Frucht-Pery; Abraham J Domb
Journal:  J Control Release       Date:  2005-09-02       Impact factor: 9.776

8.  Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.

Authors:  F F Behar-Cohen; A El Aouni; S Gautier; G David; J Davis; P Chapon; J M Parel
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

9.  Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.

Authors:  S Kevin Li; Sarah A Molokhia; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

10.  Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis.

Authors:  M Voigt; Y de Kozak; M Halhal; Y Courtois; F Behar-Cohen
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

View more
  12 in total

1.  Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.

Authors:  Poonam Chopra; Jinsong Hao; S Kevin Li
Journal:  J Control Release       Date:  2012-01-27       Impact factor: 9.776

2.  Corneal permeability assay of topical eye drop solutions in rabbits by MRI.

Authors:  Xiaochun Mao; Shaowei Zhang; Hui Hen; Longting Du; Guigang Li; Bin Li; Hong Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  MRI study of subconjunctival and intravitreal injections.

Authors:  S Kevin Li; Jinsong Hao; Hongshan Liu; Jing-huei Lee
Journal:  J Pharm Sci       Date:  2012-03-30       Impact factor: 3.534

4.  Impact of repeated topical-loaded manganese-enhanced MRI on the mouse visual system.

Authors:  Shu-Wei Sun; Tiffany Thiel; Hsiao-Fang Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-12       Impact factor: 4.799

5.  Noninvasive topical loading for manganese-enhanced MRI of the mouse visual system.

Authors:  Shu-Wei Sun; Bruce Campbell; Chantal Lunderville; Eric Won; Hsiao-Fang Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

6.  Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymers.

Authors:  Xianfeng Shi; Xin Liu; Xueming Wu; Zheng-Rong Lu; S Kevin Li; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2011-06-21       Impact factor: 4.200

7.  Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: a comparison with intravitreal injection.

Authors:  Tsen-Hsuan Lin; Chia-Wen Chiang; Kathryn Trinkaus; William M Spees; Peng Sun; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2014-01-16       Impact factor: 4.044

8.  Examination of barriers and barrier alteration in transscleral iontophoresis.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

9.  International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics.

Authors:  Hermann A M Mucke; Peter Mucke; Eva Mucke
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 10.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.